Discover how precision oncology is transforming the treatment of head and neck cancers.
Julie Bauman, MD, MPH, Dr. Cyrus Katzen Family Director of the GW Cancer Center, explains how tumor profiling, molecular testing, and targeted therapies are helping clinicians personalize care, improve outcomes, and reduce unnecessary side effects.
Dr. Bauman shares insights on:
- What precision oncology means for patients with head and neck cancer
- How genomic and biomarker testing guide individualized treatment decisions
- Advances in targeted therapies and immunotherapy
- The future of personalized cancer care and ongoing research